PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026South Asian Journal of Cancer0 citationsOpen Access

Clinical outcomes of breast cancer treated with curative intent at two newly commissioned cancer centres in India: A real-world data analysis

View Full Paper
RVRohit Avinash VadgaonkarADAbhijit DasEMEmily MacDuffie

Key Points

  • This study examines treatment patterns and clinical outcomes for breast cancer patients in India, focusing on demographic factors and survival rates.
  • Retrospective analysis of breast cancer patients treated between 2015 and 2020 at two cancer centers in India.
  • Demographic and treatment data were assessed to identify impacts on disease-free survival and overall survival.
  • Statistical analyses included Kaplan–Meier curves and multivariable Cox regression.
  • 5-year disease-free survival (DFS) rate was 79.1%, and overall survival (OS) rate was 82.9%.
  • For early breast cancer (EBC), the DFS was 86.6% and OS was 88.3%; for locally advanced breast cancer (LABC), DFS was 68% and OS was 72.8%.
  • Mastectomy and hormone receptor-negative histology were linked to worse DFS outcomes for EBC patients.

Abstract

Objectives: Breast cancer (BC) is the most common cancer in women globally and in India. This study analyzes demographic characteristics, treatment patterns, and clinical outcomes of BC patients treated at two satellite centres in India during the first five operational years. Material and Methods: All eligible women patients with BC treated between 2015 and 2020 were included in this retrospective study. Factors impacting disease-free survival (DFS) and overall survival (OS) were identified using univariate analyses with Kaplan–Meier curves and multivariable Cox regression. Results: In total, 1267 patients with a median age of 52 years early breast cancer (EBC), n = 704 (55.6%); locally advanced breast cancer (LABC), n = 563 (44.4%) were included. 5-year DFS and OS rates were 79.1% and 82.9%, respectively (EBC, 86.6% and 88.3%; LABC, 68% and 72.8%, respectively). On multivariable analysis, mastectomy and hormone receptor (HR)-negative histology were significantly associated with inferior DFS for patients with EBC. For those with LABC, DFS was adversely impacted by HR-negative histology, nodal metastasis, and chemotherapy non-receipt. Conclusion: This study provides insight into contemporary BC treatment patterns and outcomes at two newly commissioned tertiary cancer care centres in India. These findings support the viability of a hub-and-spoke model for cancer care, suggesting that quality of care can be maintained while improving geographic access to treatment and informing future interventions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vadgaonkar et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc42cdee9eb8c0dce5cdehttps://doi.org/10.25259/sajc_53_2025
Ask AI
Helpful
Bookmark
Share
View Full Paper